US Patent 11951172 Therapeutic molecules that bind to LAG3 and PD1
Patent 11951172 was granted and assigned to Crescendo Biologics on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+23 properties)
Article (+99 characters)
US Patent 11951172 Therapeutic molecules that bind to LAG3 and PD1
Article
Patent abstract
The invention relates to LAG-3 binding agents, in particular variable heavy chain (V
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Angelica Sette0
Carolyn Edwards0
David Escors Murugarren0
Isabelle Osuch0
James Legg0
Yumin Teng0
Date of Patent
April 9, 2024
0Patent Application Number
169699050
Date Filed
February 18, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11951172 Therapeutic molecules that bind to LAG3 and PD1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.